James Petersen, PA
Medical · Yakima, WANPI 1275022964
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $325 of the $459 with a category attached, or 70.7%. 7 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 50.6% of the total. 2025 is the largest year on record at $227, 4.5 times the $50 reported in 2022.
Across 17 payments — averaging $27.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$232
- Harmony Biosciences LLC$86
- Jazz Pharmaceuticals Inc.$41
- Indivior Inc.$29
- Baxter Healthcare$28
- Alkermes, Inc.$23
- plus $19 from 1 others
What the payments were for
- Travel & lodging$10723%
- Food & beverage$32571%
- Other$286%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 7 | $232 |
| Harmony Biosciences LLC | 4 | $86 |
| Jazz Pharmaceuticals Inc. | 2 | $41 |
| Indivior Inc. | 1 | $29 |
| Baxter Healthcare | 1 | $28 |
| Alkermes, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $19 |
How this compares
$459 in reported general payments places this provider in the 60th percentile of 457 medical providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $1,137 |
| Metformin Hcl | 15 | $342 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $320 |
| Gabapentin | 12 | $258 |
| Losartan Potassium | 17 | $241 |
| Metformin Hcl ErMetformin Hcl | 14 | $193 |
| Lisinopril | 21 | $178 |
| Atorvastatin Calcium | 18 | $149 |
| Zolpidem Tartrate | 115 | $122 |
| Tizanidine Hcl | 13 | $95 |
| Amlodipine Besylate | 12 | $83 |
| Trazodone Hcl | 16 | $76 |
Paid to pharmacies, not to this prescriber.
Other medical in Yakima
- Salvador LopezYakima$17K
- Jeffrey VantrobaYakima$3K
- Esther McCorkindaleYakima$3K
- Diana McFarlaneSeattle$95K
- Karissa SecoraTacoma$53K
- Tori FranklinLakewood$23K
- Amy NelsonSeattle$15K
- Rebecca JohnsonSpokane$14K
- Jonathan CyphersBurien$13K
- Jonathan WhiteSeattle$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.